Intuitive Surgical should have multiple growth drivers in an underpenetrated industry that it dominates.
HCA Healthcare is well-positioned to profit from increased demand for medical services.
Some of the most successful investors understand that the power of equity markets lies in their ability to generate consistent returns over the long run. While most traders lose money, people who invest in quality stocks and stick with them through thick and thin over long periods can build lasting generational wealth. Let's consider two stocks to invest in that can help anyone do just that: Intuitive Surgical (NASDAQ: ISRG) and HCA Healthcare (NYSE: HCA). Here's more on these healthcare leaders.
Image source: Getty Images.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Intuitive Surgical could benefit from greater adoption of robotic-assisted surgery (RAS) devices over the long run, as this market is currently underpenetrated. Surgical robots enable physicians to perform minimally invasive surgeries, which involve fewer incisions, less bleeding, and faster recovery times. Intuitive Surgical's most important product, the da Vinci system, is a leader in this niche. The company ended 2025 with an installed base of 11,106, up 12% year over year.
A large portion of Intuitive Surgical's revenue comes from selling disposable instruments and accessories that are used during surgeries. These are limited-life tools that need to be replaced frequently, generating recurring revenue for the company, especially as its installed base expands. Growing procedure volume and label expansions should also help boost the company's sales over the long run. Further, Intuitive Surgical is a highly innovative company that should continue launching newer and better versions of the da Vinci system.
There will be some challenges. Intuitive Surgical is facing increased competition from medical device giants like Medtronic and Johnson & Johnson. The company is also feeling the impact of tariffs. However, Intuitive Surgical's strong moat, stemming from switching costs and best-in-class technology that gives it the flexibility to raise prices, can allow it to overcome these obstacles. So, the stock could perform well over the long run and significantly increase shareholders' wealth.
HCA Healthcare runs a vast network of diversified healthcare facilities across the U.S., including acute care hospitals, surgery centers, urgent care centers, and more. The company will benefit from long-term secular trends, such as the world's aging population and rising demand for medical services. Although it operates in a competitive space, HCA Healthcare's strategy has allowed it to grow its market share over the past 15 years.
The company's success comes, in part, from investments in cutting-edge medical technology that helps improve patient outcomes. HCA Healthcare has also built deep relationships with payers -- both government and private -- as well as physicians and the communities it serves. That grants it a significant advantage, as this ecosystem is very hard for newcomers to replicate, even putting aside the large upfront investments required to build and run healthcare facilities.
HCA Healthcare also faces risks, especially related to changing government policy that could lead to lower reimbursement for some patients and, in turn, less demand for its services. But HCA Healthcare has traditionally managed this threat fairly well, partly through generating revenue from a fairly diversified mix of government and private health insurers. HCA Healthcare's long-term outlook is attractive. It could be a core holding in a well-performing, well-diversified portfolio.
Before you buy stock in Intuitive Surgical, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intuitive Surgical wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $513,407!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,123,237!*
Now, it’s worth noting Stock Advisor’s total average return is 938% — a market-crushing outperformance compared to 188% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of March 17, 2026.
Prosper Junior Bakiny has positions in Intuitive Surgical and Johnson & Johnson. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool recommends HCA Healthcare, Johnson & Johnson, and Medtronic and recommends the following options: long January 2028 $520 calls on Intuitive Surgical and short January 2028 $530 calls on Intuitive Surgical. The Motley Fool has a disclosure policy.